Tsimberidou AM, Hong DS, Wheler JJ, et al. Precision medicine: Clinical outcomes including long-term survival according to the pathway targeted and treatment period-The IMPACT study. J Clin Oncol. 2018;36 (suppl; abstr LBA2553).
Durvalumab na chemoradiotherapie bij stadium III niet-kleincellig longcarcinoom
aug 2018 | Longoncologie